Literature DB >> 11313390

Il-12 enhances CD8 T cell homeostatic expansion.

W C Kieper1, M Prlic, C S Schmidt, M F Mescher, S C Jameson.   

Abstract

The size of the T lymphocyte pool is maintained by regulation of T cell production, proliferation, and survival. Under the pressure of a T lymphopenic environment, mature naive T cells begin to proliferate in the absence of Ag, a process called homeostatic expansion. Homeostatic expansion involves TCR recognition of self peptide/MHC ligands, but less is known about the soluble factors that regulate this process. Here we show that IL-12 dramatically enhanced the homeostatic proliferation of CD8 T cells. In contrast, IL-2 had no beneficial effect on homeostatic expansion and, in fact, inhibited T cell expansion induced by IL-12. Using gene-targeted mice, we showed that IL-12 acted directly on the T cells to enhance homeostatic expansion, but that IL-12 cannot override the requirement for TCR interaction with self peptide/MHC ligands in homeostatic expansion. These data indicate that inflammatory cytokines may modulate T cell homeostasis after lymphopenia and have implications for regulation of the T cell repertoire and autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313390     DOI: 10.4049/jimmunol.166.9.5515

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  Homeostatic T cell proliferation in a T cell-dendritic cell coculture system.

Authors:  Qing Ge; Deborah Palliser; Herman N Eisen; Jianzhu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

Review 2.  T cell homeostasis and systemic autoimmunity.

Authors:  A N Theofilopoulos; W Dummer; D H Kono
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 3.  Adoptive therapy with CD8(+) T cells: it may get by with a little help from its friends.

Authors:  William Y Ho; Cassian Yee; Philip D Greenberg
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

4.  A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity.

Authors:  Qingsheng Li; Rajesh R Rao; Koichi Araki; Kristen Pollizzi; Kunle Odunsi; Jonathan D Powell; Protul A Shrikant
Journal:  Immunity       Date:  2011-04-22       Impact factor: 31.745

5.  Homeostatic expansion and phenotypic conversion of human T cells depend on peripheral interactions with APCs.

Authors:  Takashi Onoe; Hannes Kalscheuer; Meredith Chittenden; Guiling Zhao; Yong-Guang Yang; Megan Sykes
Journal:  J Immunol       Date:  2010-05-10       Impact factor: 5.422

Review 6.  Homeostatic T cell proliferation as a barrier to T cell tolerance.

Authors:  Somia P Hickman; Laurence A Turka
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

7.  Absence of recipient C3aR1 signaling limits expansion and differentiation of alloreactive CD8+ T cell immunity and prolongs murine cardiac allograft survival.

Authors:  Douglas R Mathern; Julian K Horwitz; Peter S Heeger
Journal:  Am J Transplant       Date:  2019-01-14       Impact factor: 8.086

8.  The roles of IL-12 and IL-23 in CD8+ T cell-mediated immunity against Listeria monocytogenes: Insights from a DC vaccination model.

Authors:  Curtis J Henry; Jason M Grayson; Kristina L Brzoza-Lewis; Latoya M Mitchell; Marlena M Westcott; Anne S Cook; Elizabeth M Hiltbold
Journal:  Cell Immunol       Date:  2010-04-24       Impact factor: 4.868

9.  IL-15 regulates both quantitative and qualitative features of the memory CD8 T cell pool.

Authors:  Michelle M Sandau; Jacob E Kohlmeier; David L Woodland; Stephen C Jameson
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

10.  The antigen-specific CD8+ T cell repertoire in unimmunized mice includes memory phenotype cells bearing markers of homeostatic expansion.

Authors:  Catherine Haluszczak; Adovi D Akue; Sara E Hamilton; Lisa D S Johnson; Lindsey Pujanauski; Lenka Teodorovic; Stephen C Jameson; Ross M Kedl
Journal:  J Exp Med       Date:  2009-02-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.